Willpower of genetic variation contained in the DYRK2gene and its associations with milk traits in cattle
To rush up the progress of marker-assisted alternative (MAS) in cattle breeding, the dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2), cadherin 2 (CDH2), and kinesin member of the household 1A (KIF1A) genes had been chosen based mostly totally on our pervious genome-wide affiliation study (GWAS) analysis outcomes. DYRK2 is a kinase that can participate in cell progress and/or progress; it reveals phosphorylation train in the direction of serine, threonine, and tyrosine fragments of proteins, and it is utterly totally different from totally different protein kinases. The CDH2 gene encodes a standard cadherin, which is a member of the cadherin superfamily.
The protein encoded by KIF1A is a member of the kinesin family and performs a activity inside the transportation of membrane organelles alongside axon microtubules. We detected insertion/deletion (InDel) variation in these three candidate genes in 438 explicit particular person cattle (Xinjiang Brown cattle and Wagyu × Luxi crossbreed cattle). Solely DYRK2-P3-11 bp was polymorphic and genotyped.
The polymorphism information content material materials of DYRK2-P3-11 bp was 0.336. Correlation analyses confirmed that InDel polymorphism was significantly associated to 6 utterly totally different milk traits. These findings may assist future analyses of InDelgenotypes in cattle breeds, and tempo up the progress of MAS in cattle breeding.
ALK kinase inhibitor-1 |
|||
T6409-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: ALK kinase inhibitor-1 |
ALK kinase inhibitor-1 |
|||
T6409-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: ALK kinase inhibitor-1 |
TAO Kinase inhibitor 1 |
|||
T16987-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
HY-112136 | MedChemExpress | 50mg | EUR 955.2 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
Pim-1 kinase inhibitor 2 |
|||
T62001-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 3 |
|||
T61074-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
AKT Kinase Inhibitor |
|||
A3150-10 | ApexBio | 10 mg | EUR 1363.2 |
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
A3150-5 | ApexBio | 5 mg | EUR 819.6 |
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
A3150-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 895.2 |
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
HY-10249A | MedChemExpress | 10mg | EUR 1052.4 |
AKT Kinase Inhibitor |
|||
T10276-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
T10276-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
T10276-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
T10276-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
T10276-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
Tie2 kinase inhibitor |
|||
E1KS1577 | EnoGene | 10mg | EUR 1147.2 |
Tie2 Kinase Inhibitor |
|||
B1338-25 | Biovision | each | EUR 907.2 |
Tie2 Kinase Inhibitor |
|||
B1338-5 | Biovision | each | EUR 314.4 |
Tie2 kinase inhibitor |
|||
A5979-100 | ApexBio | 100 mg | EUR 800 |
|
|||
Description: Tie-2(Tie2 ) inhibitor |
Tie2 kinase inhibitor |
|||
A5979-25 | ApexBio | 25 mg | EUR 240 |
|
|||
Description: Tie-2(Tie2 ) inhibitor |
Tie2 kinase inhibitor |
|||
A5979-5 | ApexBio | 5 mg | EUR 80 |
|
|||
Description: Tie-2(Tie2 ) inhibitor |
Tie2 kinase inhibitor |
|||
A5979-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 274 |
|
|||
Description: Tie-2(Tie2 ) inhibitor |
Cyclin-dependent kinase inhibitor 1 Cyclin-dependent kinase inhibitor 1A (cip1) Antibody |
|||
abx345851-100l | Abbexa | 100 µl | EUR 350 |
Cyclin-dependent kinase inhibitor 1 Cyclin-dependent kinase inhibitor 1A (cip1) Antibody |
|||
abx345851-50l | Abbexa | 50 µl | EUR 250 |
MAPKII Kinase Inhibitor |
|||
abx076811-1mg | Abbexa | 1 mg | EUR 376.8 |
|
MAPKII Kinase Inhibitor |
|||
SIH-120A | Stressmarq | 1 mg | EUR 114 |
Description: Hsp25 Kinase Inhibitor |
MAPKII Kinase Inhibitor |
|||
abx076811-100l | Abbexa | 100 µl | EUR 337.5 |
MAPKII Kinase Inhibitor |
|||
abx076811-1ml | Abbexa | 1 ml | Ask for price |
MAPKII Kinase Inhibitor |
|||
abx076811-200l | Abbexa | 200 µl | Ask for price |
Tyrosine kinase inhibitor |
|||
T17184-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Tyrosine kinase inhibitor |
Tyrosine kinase inhibitor |
|||
T17184-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Tyrosine kinase inhibitor |
Tyrosine kinase inhibitor |
|||
T17184-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Tyrosine kinase inhibitor |
Tyrosine kinase inhibitor |
|||
T17184-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Tyrosine kinase inhibitor |
Tyrosine kinase inhibitor |
|||
T17184-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Tyrosine kinase inhibitor |
Tyrosine kinase inhibitor |
|||
HY-10421 | MedChemExpress | 25mg | EUR 459.6 |
Cyclin-dependent kinase inhibitor 1 |
|||
AP81438 | SAB | 1mg | EUR 2640 |
|
Cyclin-dependent kinase inhibitor 1 |
|||
AP81644 | SAB | 1mg | EUR 2640 |
|
Aurora kinase inhibitor-10 |
|||
T63853-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-10 |
Aurora kinase inhibitor-10 |
|||
T63853-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Aurora kinase inhibitor-10 |
Aurora kinase inhibitor-10 |
|||
T63853-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-10 |
Aurora kinase inhibitor-10 |
|||
T63853-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-10 |
Aurora kinase inhibitor-10 |
|||
T63853-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-10 |
IKK-? Kinase Inhibitor II |
|||
1811-1 | Biovision | each | EUR 189.6 |
IKK-? Kinase Inhibitor II |
|||
1811-5 | Biovision | each | EUR 574.8 |
Aurora kinase inhibitor-8 |
|||
T63773-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-8 |
Aurora kinase inhibitor-8 |
|||
T63773-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Aurora kinase inhibitor-8 |
Aurora kinase inhibitor-8 |
|||
T63773-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-8 |
Aurora kinase inhibitor-8 |
|||
T63773-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-8 |
Aurora kinase inhibitor-8 |
|||
T63773-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-8 |
Aurora kinase inhibitor-9 |
|||
T62789-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-9 |
Aurora kinase inhibitor-9 |
|||
T62789-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Aurora kinase inhibitor-9 |
Aurora kinase inhibitor-9 |
|||
T62789-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-9 |
Aurora kinase inhibitor-9 |
|||
T62789-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Aurora kinase inhibitor-9 |
Genetic variants in N6-methyladenosine are associated to bladder most cancers risk inside the Chinese language language inhabitants
Not too way back N6-Methyladenosine (m6A) has been acknowledged to info the interaction of RNA-binding protein hnRNP C and their purpose RNAs, which is termed as m6A-switches. We systematically investigated the affiliation between genetic variants in m6A-switches and bladder most cancers risk. A two-stage case-control study was carried out to systematically calculate the affiliation of single nucleotide polymorphisms (SNPs) in 2798 m6A-switches with bladder most cancers risk in 3,997 subjects.
A logistic regression model was used to guage the outcomes of SNPs on bladder most cancers risk. A group of experiments had been adopted to find the operate of genetic variants of m6A-switches. We acknowledged that rs5746136 (G > A) of SOD2 in m6A-switches was significantly associated to the diminished risk of bladder most cancers (additive model in discovery stage: OR = 0.80, 95% CI 0.69-0.93, P = 3.6 × 10-3; validation stage: adjusted OR = 0.88, 95% CI 0.79-0.99, P = 3.0 × 10-2; combined analysis: adjusted OR = 0.85, 95% CI 0.78-0.93, P = 4.0 × 10-4).
The mRNA stage of SOD2 was remarkably lower in bladder most cancers tissues than the paired adjoining samples. SNP rs5746136 may affect m6A modification and regulate SOD2 expression by guiding the binding of hnRNP C to SOD2, which carried out a important tumor suppressor operate in bladder most cancers cells by promoting cell apoptosis and inhibiting proliferation, migration and invasion.
In conclusion, our findings counsel the important operate of genetic variants in m6A modification. SOD2 polymorphisms may have an effect on the expression of SOD2 by an m6A-hnRNP C-dependent mechanism and be promising predictors of bladder most cancers risk.
Weight reduction plan Modifies Pioglitazone’s Have an effect on on Hepatic PPAR γ-Regulated Mitochondrial Gene Expression
- Pioglitazone (Pio) is a thiazolidinedione (TZD) insulin-sensitizing drug whose outcomes finish outcome predominantly from its modulation of the transcriptional train of peroxisome proliferator-activated-receptor-gamma (PPARγ). Pio is used to cope with human insulin-resistant diabetes and as well as ceaselessly thought-about for remedy of nonalcoholicsteatohepatitis (NASH).
- In every settings, Pio’s useful outcomes are believed to finish outcome primarily from its actions on adipose PPARγ train, which improves insulin sensitivity and reduces the provision of fatty acids to the liver. Nonetheless, a modern medical trial confirmed variable efficacy of Pio in human NASH.
- Hepatocytes moreover particular PPARγ, and such expression will improve with insulin resistance and in nonalcoholic fatty liver sickness (NAFLD). Furthermore, mice that overexpress hepatocellular PPARγ and Pio-treated mice with extrahepatic PPARγ gene disruption develop choices of NAFLD. Thus, Pio’sdirect affect on hepatocellular gene expression may be a determinant of this drug’s remaining have an effect on on insulin resistance and NAFLD. Earlier analysis have characterised Pio’sPPARγ-dependent outcomes on hepatic expression of explicit adipogenic, lipogenic, and totally different metabolic genes.
- Nonetheless, such transcriptional regulation has not been comprehensively assessed. The analysis reported proper right here cope with that consideration by genome-wide comparisons of Pio’s hepatic transcriptional ends in wildtype (WT) and liver-specific PPARγ-knockout (KO) mice given each administration or high-fat (HFD) diets. The outcomes set up an enormous set of hepatic genes for which Pio’s liver PPARγ-dependent transcriptional outcomes are concordant with its outcomes on RXR-DNA binding in WT mice.
- These info moreover current that HFD modifies Pio’s have an effect on on a subset of such transcriptional regulation. Lastly, our findings reveal a broader have an effect on of Pio on PPARγ-dependent hepatic expression of nuclear genes encoding mitochondrial proteins than beforehand acknowledged. Taken collectively, these analysis current new insights regarding the tissue-specific mechanisms by which Pio impacts hepatic gene expression and the broad scope of this drug’s have an effect on on such regulation.
HIV-1 p24 recombinant antigen, |
|||
00174-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 p24 recombinant antigen. |
HIV-1 p24 recombinant antigen. |
|||
00174-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 p24 recombinant antigen. |
HIV-1 p24 recombinant antigen |
|||
9002 | Virostat | 100 ug | EUR 712.5 |
Description: This is HIV-1 p24 recombinant antigen for ELISA,WB. |
HIV-1 p24 recombinant antigen |
|||
8909 | Virostat | 100 ug | EUR 608.1 |
Description: This is HIV-1 p24 recombinant antigen for ELISA,WB. |
HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations) |
|||
0801002 | Cusabio | 96T | EUR 657.79 |
|
|||
Description: Please contact Gentaur in order to receive the datasheet of the product. |
HIV-P24 antigen array kit |
|||
VArk-Lsx001 | Creative Biolabs | unit | Ask for price |
Description: Fourth-generation HIV immunoassays detect viral p24 protein in the blood. |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
|||
abx257575-05mg | Abbexa | 0.5 mg | Ask for price |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
|||
abx257575-100g | Abbexa | 100 µg | EUR 468.75 |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
|||
abx257575-1mg | Abbexa | 1 mg | Ask for price |
HIV-1 p17-p24 recombinant antigen. |
|||
00172-V | Virogen | 1 MG | EUR 850 |
HIV-1 p17-p24 recombinant antigen. |
|||
00172-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 p17-p24 recombinant antigen. |
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
|||
0801200 | Zeptometrix | 5 X 96T | EUR 2563 |
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
|||
801200 | Zeptometrix | 5 X 96 Determinations | EUR 2563 |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV 1 p24 core recombinant antigen. |
|||
00177-V | Virogen | 1 MG | EUR 850 |
HIV 1 p24 core recombinant antigen |
|||
00177-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen |
|||
00177-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen. |
|||
00177-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV 1 p24 core recombinant antigen. |
HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations) |
|||
0801008 | Zeptometrix | 5 X 96T | EUR 2505 |
Human HIV(1+2 antibodies plus p24 antigen (4th Generation) ELISA Kit |
|||
EH4101 | FN Test | 96T | EUR 571.5 |
|
|||
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
|||
MAB12321-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
|||
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
|||
MAB12321-500 | The Native Antigen Company | 0.5 | EUR 671.04 |
|
|||
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
NSL1389Hu | Sunlong | 96 wells | EUR 468 |
|
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
|||
REC31743-100 | The Native Antigen Company | 0.1 | EUR 496.27 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
|||
REC31743-500 | The Native Antigen Company | 0.5 | EUR 1363.78 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
HIV-1 p24 ELISA Kit |
|||
Z7040001 | Biochain | 1 kit | EUR 865 |
Bovine HIV-1 p24 core protein(HIV-1 p24) Anti-body ELISA Kit |
|||
NSL1181Bo | Sunlong | 96 T | EUR 528 |
|
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
EK11777 | SAB | 96Т | EUR 799 |
|
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
AE62582HU-48Tests | Abebio | 48 Tests | EUR 360 |
|
|||
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
AE62582HU-96Tests | Abebio | 96 Tests | EUR 680 |
|
|||
Description: Human (Homo sapiens) |
OPEF01414-1MG - Recombinant Human Immunodeficiency Virus 1 (HIV 1-p24) Antigen |
|||
OPEF01414-1MG | Aviva Systems Biology | 1mg | EUR 2216 |
|
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
00111-V | Virogen | 1 MG | EUR 850 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
00111-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 p17/24/gp120 antigen |
|||
00169-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 p17/24/gp120 antigen |
|||
00169-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 nef antigen |
|||
GWB-633F8F | GenWay Biotech | 0.5 mg | Ask for price |
Astrovirus Antigen (Type 1) |
|||
AS02-1000 | The Native Antigen Company | 1.0 | EUR 1654.65 |
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
Astrovirus Antigen (Type 1) |
|||
AS02-200 | The Native Antigen Company | 0.2 | EUR 442.69 |
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
Canine Adenovirus 1 Antigen |
|||
NAT41587-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Adenovirus Type 1, produced in A-72 cells. |
HIV-1 intergase antigen |
|||
00199-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
HIV-1 intergase antigen |
|||
00199-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
Herpes Simplex Virus 1 Antigen |
|||
HS105-1000 | The Native Antigen Company | 1.0 | EUR 1178.79 |
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
Herpes Simplex Virus 1 Antigen |
|||
HS105-200 | The Native Antigen Company | 0.2 | EUR 294.7 |
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
HIV-1 p24 (HIV-1) |
|||
GWB-420F7B | GenWay Biotech | 0.1 mg | Ask for price |
|
Canine Adenovirus 1 and 2 Antigen |
|||
NAT41589-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells. |
Herpes Simplex Virus 1 Lysate Antigen |
|||
HS104-1000 | The Native Antigen Company | 1.0 | EUR 270.46 |
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate. |
HIV-1 p24 Antibody |
|||
GWB-26647C | GenWay Biotech | 0.1 mg | Ask for price |
|
HIV-1 p24, Antibody |
|||
GWB-2D04FA | GenWay Biotech | 0.1 mg | Ask for price |
|
HIV-1 p24, Antibody |
|||
GWB-2DD7E0 | GenWay Biotech | 0.1 mg | Ask for price |
|
HIV-1 p24, Antibody |
|||
GWB-3B2FFB | GenWay Biotech | 1 mg | Ask for price |
|
HIV-1 p24 Antibody |
|||
GWB-4CB110 | GenWay Biotech | 1 ml | Ask for price |
|
HIV-1 p24, Antibody |
|||
GWB-192382 | GenWay Biotech | 0.1 mg | Ask for price |
|
HIV-1 p24 Antibody |
|||
7313-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
|||
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
HIV-1 p24 Antibody |
|||
7313-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
|||
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
HIV-1 p24 Antibody |
|||
20-abx137062 | Abbexa |
|
|
|
HIV-1 p24 Antibody |
|||
abx023925-1mg | Abbexa | 1 mg | EUR 828 |
|
HIV-1 p24 Antibody |
|||
abx023926-1mg | Abbexa | 1 mg | EUR 828 |
|
HIV-1 p24 Antibody |
|||
abx021869-1mg | Abbexa | 1 mg | EUR 794.4 |
|
HIV-1 p24 Antibody |
|||
abx021870-1mg | Abbexa | 1 mg | EUR 760.8 |
|
HIV-1 p24 Antibody |
|||
abx021871-1mg | Abbexa | 1 mg | EUR 794.4 |
|
HIV-1 p24 Antibody |
|||
abx021872-1mg | Abbexa | 1 mg | EUR 794.4 |
|
HIV-1 p24 Antibody |
|||
abx021873-1mg | Abbexa | 1 mg | EUR 794.4 |
|
HIV-1 p24 Antibody |
|||
abx021882-1mg | Abbexa | 1 mg | EUR 1178.4 |
|
HIV-1 p24 Antibody |
|||
abx021883-1mg | Abbexa | 1 mg | EUR 1220.4 |
|
HIV-1 p24 Antibody |
|||
abx021886-1mg | Abbexa | 1 mg | EUR 1220.4 |
|
HIV-1 p24 Antibody |
|||
abx021887-1mg | Abbexa | 1 mg | EUR 1220.4 |
|
HIV-1 p24 Antibody |
|||
abx021888-1mg | Abbexa | 1 mg | EUR 1220.4 |
|
HIV-1 p24 Antibody |
|||
abx023027-1ml | Abbexa | 1 ml | EUR 693.6 |
|
HIV-1 p24, Antibody |
|||
GWB-B0158C | GenWay Biotech | 0.1 mg | Ask for price |
HIV-1 p24, Antibody |
|||
GWB-9C0291 | GenWay Biotech | 0.1 mg | Ask for price |
HIV-1 p24 Antibody |
|||
GWB-9EAC4B | GenWay Biotech | 1 ml | Ask for price |
HIV-1 p24 Antibody |
|||
GWB-846CEC | GenWay Biotech | 1 ml | Ask for price |
HIV-1 p24 Antibody |
|||
GWB-76A9C7 | GenWay Biotech | 0.1 mg | Ask for price |
HIV-1 p24 Antibody |
|||
GWB-F48F6D | GenWay Biotech | 0.1 mg | Ask for price |
HIV-1 p24 Antibody |
|||
GWB-BBDE10 | GenWay Biotech | 1 ml | Ask for price |
HIV-1 p24 Antibody |
|||
GWB-F1D71D | GenWay Biotech | 0.1 mg | Ask for price |
HIV-1 p24 Antibody |
|||
abx021869-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021869-80l | Abbexa | 80 µl | EUR 937.5 |
HIV-1 p24 Antibody |
|||
abx021871-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021871-80l | Abbexa | 80 µl | EUR 937.5 |
HIV-1 p24 Antibody |
|||
abx021872-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021872-80l | Abbexa | 80 µl | EUR 937.5 |
HIV-1 p24 Antibody |
|||
abx021873-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021873-80l | Abbexa | 80 µl | EUR 937.5 |
HIV-1 p24 Antibody |
|||
abx021882-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021882-80l | Abbexa | 80 µl | EUR 1237.5 |
HIV-1 p24 Antibody |
|||
abx021883-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021883-80l | Abbexa | 80 µl | EUR 1237.5 |
HIV-1 p24 Antibody |
|||
abx021886-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021886-80l | Abbexa | 80 µl | EUR 1237.5 |
HIV-1 p24 Antibody |
|||
abx021887-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021887-80l | Abbexa | 80 µl | EUR 1587.5 |
HIV-1 p24 Antibody |
|||
abx021888-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021888-80l | Abbexa | 80 µl | EUR 1237.5 |
HIV-1 p24 Antibody |
|||
abx023027-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx023027-80l | Abbexa | 80 µl | EUR 1012.5 |
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
NAT41582-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
NAT41582-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
HIV-1 p24 |
|||
E62H002 | EnoGene | 100ug | EUR 255 |
HIV-1 p24 |
|||
E5-00024 | EnoGene | 1mg | EUR 700 |
HIV-1 p24 |
|||
GWB-3A5505 | GenWay Biotech | 0.1 mg | Ask for price |
|
HIV-1 p24 |
|||
GWB-1A0810 | GenWay Biotech | 1 mg | Ask for price |
|
HIV-1 p24 |
|||
ant-152 | ProSpec Tany | 0.5mg | EUR 275 |
Description: Mouse Anti HIV-1 p24 |
HIV-1 p24 |
|||
GWB-B96BB9 | GenWay Biotech | 1 mg | Ask for price |
HIV-1 p24 |
|||
hiv-006 | ProSpec Tany | 100µg | EUR 130 |
Description: Recombinant HIV-1 p24 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p17 (1981) |
|||
MAB12320-100 | The Native Antigen Company | 0.1 | EUR 310.01 |
|
|||
Description: Mouse monoclonal antibody specific for HIV-1 p17 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p17 (1981) |
|||
MAB12320-500 | The Native Antigen Company | 0.5 | EUR 770.55 |
|
|||
Description: Mouse monoclonal antibody specific for HIV-1 p17 |
HIV-1 tat recombinant antigen |
|||
00110-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 tat recombinant antigen |
|||
00110-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 gag recombinant antigen |
|||
8934 | Virostat | 100 ug | EUR 542.86 |
Description: This is HIV-1 gag recombinant antigen for ELISA,WB. |
HIV-1 nef recombinant antigen |
|||
8941 | Virostat | 100 ug | EUR 477.6 |
Description: This is HIV-1 nef recombinant antigen for ELISA,WB. |
p24 (HIV-1) |
|||
GWB-549FE4 | GenWay Biotech | 0.5 ml | Ask for price |
|
HIV-1 gp41 recombinant antigen. |
|||
00170-V | Virogen | 1 MG | EUR 850 |
HIV-1 gp41 recombinant antigen, |
|||
00170-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 gp41 recombinant antigen. |
HIV-1 gp41 recombinant antigen, |
|||
00170-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 gp41 recombinant antigen. |
HIV-1 gp41 recombinant antigen. |
|||
00170-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 gp41 recombinant antigen. |
HIV-1 gp41 recombinant antigen |
|||
9000 | Virostat | 100 ug | EUR 484.13 |
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB. |
HIV-1 gp41 recombinant antigen |
|||
9001 | Virostat | 100 ug | EUR 484.13 |
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB. |
HIV-1 gp41 recombinant antigen |
|||
8908 | Virostat | 100 ug | EUR 673.36 |
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB. |
HIV-1 gp41 recombinant antigen |
|||
8933 | Virostat | 100 ug | EUR 477.6 |
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB. |
Borrelia Afzelii Antigen |
|||
NAT41583-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
Borrelia Afzelii Antigen |
|||
NAT41583-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
Borrelia Garinii Antigen |
|||
NAT41584-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
Borrelia Garinii Antigen |
|||
NAT41584-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
Brucella Abortus Antigen |
|||
NAT41599-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Brucella abortus lysate, produced by fermentation. |
Brucella Abortus Antigen |
|||
NAT41599-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Brucella abortus lysate, produced by fermentation. |
Candida Albicans Antigen |
|||
NAT41601-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
Candida Albicans Antigen |
|||
NAT41601-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
Canine Parvovirus Antigen |
|||
NAT41594-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Parvovirus, produced in CRFK cells. |
Canine Coronavirus Antigen |
|||
NAT41590-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Coronavirus produced in A-72 cells. |
Feline Calicivirus Antigen |
|||
NAT41595-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Feline Calicivirus produced in FC 3TG cells. |
Helicobacter Pylori Antigen |
|||
NAT41603-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
Helicobacter Pylori Antigen |
|||
NAT41603-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
Campylobacter Jejuni Antigen |
|||
NAT41600-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
Campylobacter Jejuni Antigen |
|||
NAT41600-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
Chlamydia Trachomatis Antigen |
|||
CT022-1000 | The Native Antigen Company | 1.0 | EUR 378.9 |
Description: Chlamydia trachomatis antigens from clarified cell lysate. |
Mycoplasma Pneumoniae Antigen |
|||
MP901-1000 | The Native Antigen Company | 1.0 | EUR 1010.39 |
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
Mycoplasma Pneumoniae Antigen |
|||
MP901-200 | The Native Antigen Company | 0.2 | EUR 270.46 |
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
Echovirus Antigen, Recombinant |
|||
REC31776-100 | The Native Antigen Company | 0.1 | EUR 276.84 |
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
Echovirus Antigen, Recombinant |
|||
REC31776-500 | The Native Antigen Company | 0.5 | EUR 1043.56 |
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
Neisseria Gonorrhoeae Antigen |
|||
NG01-1000 | The Native Antigen Company | 1.0 | EUR 378.9 |
Description: Homogenised lysate of pure bacteria. |
Trichomonas Vaginalis Antigen |
|||
TV01-1000 | The Native Antigen Company | 1.0 | EUR 421 |
Description: Washed & lysed suspension of whole protozoa |
HIV-1 Antibody (p24) |
|||
GWB-44F330 | GenWay Biotech | 0.1 mg | Ask for price |
HIV-1 Antibody (p24) |
|||
GWB-Q00547 | GenWay Biotech | 1 mg | Ask for price |
HIV-1 Antibody (p24) |
|||
GWB-T00244 | GenWay Biotech | 1 mg | Ask for price |
HIV-1 Antibody (p24) |
|||
GWB-T00398 | GenWay Biotech | 1 mg | Ask for price |
HIV-1 Antibody (p24) |
|||
GWB-T00747 | GenWay Biotech | 0.5 mg | Ask for price |
HIV-1 Antibody (p24) |
|||
GWB-CF4E51 | GenWay Biotech | 1 ml | Ask for price |
Enterovirus Antigen, Recombinant |
|||
REC31772-100 | The Native Antigen Company | 0.1 | EUR 276.84 |
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
Enterovirus Antigen, Recombinant |
|||
REC31772-500 | The Native Antigen Company | 0.5 | EUR 1043.56 |
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
Echinococcus Granulosus Antigen |
|||
NAT41602-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
Echinococcus Granulosus Antigen |
|||
NAT41602-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
Cytomegalovirus Purified Antigen |
|||
CMV-HP-100 | The Native Antigen Company | 0.1 | EUR 318.94 |
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
Cytomegalovirus Purified Antigen |
|||
CMV-HP-1000 | The Native Antigen Company | 1.0 | EUR 2096.06 |
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
Cytomegalovirus Purified Antigen |
|||
CMV-HP-500 | The Native Antigen Company | 0.5 | EUR 1279.58 |
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
Yersinia pestis V antigen |
|||
REC32028-100 | The Native Antigen Company | 0.1 | EUR 491.53 |
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
Yersinia pestis V antigen |
|||
REC32028-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
HIV p24 Antibody |
|||
GWB-3F4E8C | GenWay Biotech | 1 mg | Ask for price |
|
HIV p24 Antibody |
|||
abx021867-1mg | Abbexa | 1 mg | EUR 1612.8 |
|
HIV p24 Antibody |
|||
abx021868-1mg | Abbexa | 1 mg | EUR 1612.8 |
|
HIV p24 Antibody |
|||
GWB-A348DD | GenWay Biotech | 1 mg | Ask for price |
HIV p24 Antibody |
|||
GWB-A9F8C7 | GenWay Biotech | 1 mg | Ask for price |
HIV p24 Antibody |
|||
GWB-82D06B | GenWay Biotech | 1 mg | Ask for price |
HIV p24 Antibody |
|||
GWB-83EEA8 | GenWay Biotech | 1 mg | Ask for price |
HIV p24 Antibody |
|||
GWB-FDA891 | GenWay Biotech | 1 mg | Ask for price |
HIV p24 Antibody |
|||
abx021867-400l | Abbexa | 400 µl | Ask for price |
HIV p24 Antibody |
|||
abx021867-80l | Abbexa | 80 µl | EUR 937.5 |
HIV p24 Antibody |
|||
abx021868-400l | Abbexa | 400 µl | Ask for price |
HIV p24 Antibody |
|||
abx021868-80l | Abbexa | 80 µl | EUR 1500 |
Canine Herpes Virus Antigen |
|||
NAT41592-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Herpes virus, produced in MDCK cells. |
HIV-1 p24 (HIV-1) recombinant |
|||
GWB-FE5FE0 | GenWay Biotech | 0.1 mg | Ask for price |
Canine Adenovirus 2 Antigen |
|||
NAT41588-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Adenovirus Type 2, produced in A-72 cells. |
Canine Distemper Virus Antigen |
|||
NAT41591-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Distemper virus, produced in SL-29 cells. |
HIV-1 p17/24/gp120-gp41 recombinant antigen. |
|||
00168-V | Virogen | 1 MG | EUR 850 |
HIV-1 p17/24/gp120-gp41 recombinant antigen, |
|||
00168-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen. |
HIV-1 p17/24/gp120-gp41 recombinant antigen, |
|||
00168-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen. |
HIV-1 p17/24/gp120-gp41 recombinant antigen. |
|||
00168-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen. |
HTLV-I p24 Antigen |
|||
GWB-DF0617 | GenWay Biotech | 1 mg | Ask for price |
HIV 1 envelope recombinant antigen |
|||
00176-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. |
HIV 1 envelope recombinant antigen |
|||
00176-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. |
Norovirus GII.4 VP1 Antigen |
|||
REC31620-100 | The Native Antigen Company | 0.1 | EUR 302.36 |
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
Norovirus GII.4 VP1 Antigen |
|||
REC31620-1000 | The Native Antigen Company | 1.0 | EUR 1830.71 |
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
Norovirus GII.4 VP1 Antigen |
|||
REC31620-500 | The Native Antigen Company | 0.5 | EUR 1066.53 |
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
Canine Parainfluenza Virus Antigen |
|||
NAT41593-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Parainfluenza virus antigen, produced in MDCK cells. |
Feline Panleukopenia Virus Antigen |
|||
NAT41597-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells. |
HIV-1 p24 Antibody (HRP) |
|||
abx023029-1ml | Abbexa | 1 ml | EUR 886.8 |
|
HIV-1 p24 Antibody [8G9] |
|||
PM-6335-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
|||
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3). |